[Clinical results of a new soluble derivative of the tetracycline series].
D000900:Anti-Bacterial Agents; D007239:Infections / Q000628:therapy*; D011500:Protein Synthesis Inhibitors; D013754:Tetracyclines; D014777:Virus Diseases / Q000628:therapy*
D000900:Anti-Bacterial Agents; D011500:Protein Synthesis Inhibitors; D013754:Tetracyclines
INFECTION/therapy; TETRACYCLINE/related compounds; VIRUS DISEASES/therapy